January 25, 2023CorporateTerumo and Siemens Healthineers India collaborate to strengthen cardiac care in India
January 18, 2023CorporateFirst Patient Treated and Enrolled in Terumo Medical Corporation’s Osprey Iliac IDE Clinical TrialTrial aims to assure Terumo’s Misago® RX Self-expanding Peripheral Stent is safe and effective
Top Management Message Message from top management to shareholders and investors. /investors/management/message Corporate Governance /about/governance Compliance /about/compliance Leadership Team /about/leadership Business Risks Major risks that may affect the business performance and financial position of the Terumo Group are described. /investors/management/risk IR Policy /investors/management/ir_policy Disclaimer /investors/disclaimer